Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.

Hypertension (Dallas, Tex. : 1979) - 1 Feb 2008

Nakamura Taishi, Yamamoto Eiichiro, Kataoka Keiichiro, Yamashita Takuro, Tokutomi Yoshiko, Dong Yi-Fei, Matsuba Shinji, Ogawa Hisao, Kim-Mitsuyama Shokei

Abstract excerpt

The effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on hypertensive cardiovascular injury is unknown. We examined the effect of pioglitazone on hypertensive cardiovascular injury and the significance of combination of pioglitazone with angiotensin type 1 recept...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Biphenyl Compounds

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomegaly

Share to Pioglitazone

Share to Rats, Inbred WKY

Share to Tetrazoles

Share to Thiazolidinediones

Share to Ventricular Remodeling

Source

Identifiers

PMID: 18158350
DOI: 10.1161/HYPERTENSIONAHA.107.099044

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18158350-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.PMID 18158350Read ↗

Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature.Semantic proximity Read ↗

Regulation of cardiovascular diseases by histone deacetylases and NADPH oxidasesSemantic proximity Read ↗

Targeting mitochondria-inflammation circle by renal denervation reduces atheroprone endothelial phenotypes and atherosclerosis.Semantic proximity Read ↗

Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies.Semantic proximity Read ↗

Reactive Oxygen Species: Modulators of Phenotypic Switch of Vascular Smooth Muscle Cells.Semantic proximity Read ↗

Canagliflozin alleviates pulmonary hypertension partially by inhibition of PPARγ S225 phosphorylation and PPARγ-mediated suppression of oxidative stressSemantic proximity Read ↗

Inhibition of reactive oxygen species generation attenuates TLR4-mediated proinflammatory and proliferative phenotype of vascular smooth muscle cells.Semantic proximity Read ↗

Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice.Semantic proximity Read ↗

Novel aspects of oxidative stress in cardiovascular diseases.Semantic proximity Read ↗

Lipotoxicity, glucotoxicity and some strategies to protect vascular smooth muscle cell against proliferative phenotype in metabolic syndrome.Semantic proximity Read ↗

MIR-128 TARGETING PPAR-γ IMPROVES VASCULAR REMODELING IN SPONTANEOUSLY HYPERTENSIVE RATS BY REGULATING THE TLR4/NFKB INFLAMMATORY PATHWAYSemantic proximity Read ↗

Cholinergic Stimulation Exerts Cardioprotective Effects and Alleviates Renal Inflammatory Responses after Acute Myocardial Infarction in Spontaneous Hypertensive Rats (SHRs)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.